These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 1967930

  • 21. Neu differentiation factor (heregulin) induces expression of intercellular adhesion molecule 1: implications for mammary tumors.
    Bacus SS, Gudkov AV, Zelnick CR, Chin D, Stern R, Stancovski I, Peles E, Ben-Baruch N, Farbstein H, Lupu R.
    Cancer Res; 1993 Nov 01; 53(21):5251-61. PubMed ID: 8106145
    [Abstract] [Full Text] [Related]

  • 22. HER-2/neu and p53 overexpression as biomarkers of breast carcinoma in women age 30 years and younger.
    Maru D, Middleton LP, Wang S, Valero V, Sahin A.
    Cancer; 2005 Mar 01; 103(5):900-5. PubMed ID: 15643600
    [Abstract] [Full Text] [Related]

  • 23. Expression of c-erb B-2 protein and DNA ploidy in breast carcinogenesis.
    Schmitt FC, Figueiredo P, Lacerda M.
    Arch Pathol Lab Med; 1995 Sep 01; 119(9):815-20. PubMed ID: 7668939
    [Abstract] [Full Text] [Related]

  • 24. Determination of Her-2/Neu status in breast carcinoma: comparative analysis of immunohistochemistry and fluorescent in situ hybridization.
    Jimenez RE, Wallis T, Tabasczka P, Visscher DW.
    Mod Pathol; 2000 Jan 01; 13(1):37-45. PubMed ID: 10658908
    [Abstract] [Full Text] [Related]

  • 25. Immunodetection of HER-2/neu protein in frozen sections evaluated by image analysis: correlation with overall and disease-free survival in breast carcinomas.
    Charpin C, Bonnier P, Devictor B, Andrac L, Lavaut MN, Allasia C, Piana L.
    Anticancer Res; 1993 Jan 01; 13(3):603-12. PubMed ID: 8100412
    [Abstract] [Full Text] [Related]

  • 26. Comparison of multiplex ligation dependent probe amplification to immunohistochemistry for assessing HER-2/neu amplification in invasive breast cancer.
    Purnomosari D, Aryandono T, Setiaji K, Nugraha SB, Pals G, van Diest PJ.
    Biotech Histochem; 2006 Jan 01; 81(2-3):79-85. PubMed ID: 16908432
    [Abstract] [Full Text] [Related]

  • 27. Immunohistochemical study of HER-2/neu, epidermal growth factor receptor, and steroid receptor expression in normal and malignant endometrium.
    Bigsby RM, Li AX, Bomalaski J, Stehman FB, Look KY, Sutton GP.
    Obstet Gynecol; 1992 Jan 01; 79(1):95-100. PubMed ID: 1345772
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. HER-2/neu oncogene expression and DNA ploidy in normal human kidney and renal cell carcinoma.
    Danova M, Giordano M, Torelli F, Franchini G, Cappellano F, Riccardi A, Catanzaro F, Mazzini G.
    Eur J Histochem; 1992 Jan 01; 36(3):279-88. PubMed ID: 1281010
    [Abstract] [Full Text] [Related]

  • 30. The role of the HER-2/neu oncogene in gynecologic cancers.
    Cirisano FD, Karlan BY.
    J Soc Gynecol Investig; 1996 Jan 01; 3(3):99-105. PubMed ID: 8796816
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Multivariate analysis of bcl-2, apoptosis, P53 and HER-2/neu in breast cancer: a short-term follow-up.
    el-Ahmady O, el-Salahy E, Mahmoud M, Wahab MA, Eissa S, Khalifa A.
    Anticancer Res; 2002 Jan 01; 22(4):2493-9. PubMed ID: 12174951
    [Abstract] [Full Text] [Related]

  • 33. Differences in the pathologic and molecular features of intraductal breast carcinoma between younger and older women.
    Rodrigues NA, Dillon D, Carter D, Parisot N, Haffty BG.
    Cancer; 2003 Mar 15; 97(6):1393-403. PubMed ID: 12627502
    [Abstract] [Full Text] [Related]

  • 34. HER-2/neu amplification predicts poor survival in node-positive breast cancer.
    Borg A, Tandon AK, Sigurdsson H, Clark GM, Fernö M, Fuqua SA, Killander D, McGuire WL.
    Cancer Res; 1990 Jul 15; 50(14):4332-7. PubMed ID: 1973070
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Preferred genetic evolutionary sequences in human breast cancer: a case study.
    Shackney SE, Smith CA, Pollice AA, Janocko LE, Singh SG, Groft DW, Brown KA, Hartsock RJ.
    Cytometry; 1995 Sep 01; 21(1):6-13. PubMed ID: 8529472
    [Abstract] [Full Text] [Related]

  • 38. Tyrosine kinase activation in breast carcinoma with correlation to HER-2/neu gene amplification and receptor overexpression.
    Bhargava R, Naeem R, Marconi S, Luszcz J, Garb J, Gasparini R, Otis CN.
    Hum Pathol; 2001 Dec 01; 32(12):1344-50. PubMed ID: 11774167
    [Abstract] [Full Text] [Related]

  • 39. HER-2/neu oncogene expression in advanced breast cancer.
    Krogerus LA, Leivonen M.
    Cancer Detect Prev; 2001 Dec 01; 25(1):1-7. PubMed ID: 11270416
    [Abstract] [Full Text] [Related]

  • 40. Biological correlation between HER-2/neu and proliferative activity in human breast cancer.
    Tommasi S, Paradiso A, Mangia A, Barletta A, Simone G, Slamon DJ, De Lena M.
    Anticancer Res; 1991 Dec 01; 11(4):1395-400. PubMed ID: 1684096
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.